04/07/2025
VAZ was represented by the Vice Secretary Dr Mbawe Zulu
ZAMRA HOLDS QUALITY ASSURANCE MEETING FOR SUPPLY CHAIN STAKEHOLDERS
On 3rd July, 2025, ZAMRA engaged stakeholders in the pharmaceutical supply chain to to formulate a sampling plan of medicines and allied substances.
The meeting was aimed at selecting products for focus in the continuous quality monitoring in 2026 under the Post Marketing Surveillance (PMS).
PMS is a vital regulatory function that monitors the quality of medicines and allied substances at all levels of the supply chain, throughout their shelf-life.
This is important in ensuring that medicines and allied substances used by the public consistently meet the standard of quality, safety and efficacy (or performance).
Opening the meeting, ZAMRA Director-General, Mr. Makomani Siyanga, highlighted the importance of stakeholders in the fight against substandard and falsified medical products.
He highlighted the significance of coordination among stakeholders who include supply chain actors, health professionals and the general public.
Stakeholders came from the Ministry of Health, Ministry of Livestock and Fisheries, Zambia Medicines and Medical Supplies Agency (ZAMMSA), Churches Health Association of Zambia (CHAZ), Zambia Pharmaceutical Business Forum (ZPBF), Global Health Supply Chain Program - Procurement and Supply Management (GHSC-PSM), and the Hospital Pharmacists Association of Zambia (HOPAZ). Others were Veterinary Association of Zambia (VAZ) and the Pharmaceutical Society of Zambia (PSZ).
Products earmarked for sampling include medicines for human and animal health, and allied substances such as medical devices among others.
Strengthened vigilance and market surveillance and control are key in safeguarding public health from unsafe substandard and falsified medicines and allied substances.